The first indication in support for the anti-tumor effect of cannabinoids in glioma emerged from studies describing epidermal growth factor receptors (EGFR) ligand amphiregulin increases the resistance to Δ9-THC antitumor effect in glioma xenograft [257,588]. Here, EGFR is linked to central nervous system cancer.